Skip to main content
. Author manuscript; available in PMC: 2019 Dec 19.
Published in final edited form as: JACC Cardiovasc Interv. 2016 Aug 22;9(16):1694–1702. doi: 10.1016/j.jcin.2016.05.039

TABLE 1.

Baseline Characteristics

Overall
(N ¼ 14,171)
Patients
With PCI
(n ¼ 153)
Patients
Without PCI
(n = 14,018)
p Value
Age, yrs 73 (65, 78) 73 (67, 79) 73 (65, 78) 0.305
Female 5,605 (39.6) 27 (17.6) 5,578 (39.8) <0.001
BMI, kg/m2 28.2 (25.1, 32.0) 28.9 (26.0, 32.4) 28.2 (25.1, 32.00 0.105
SBP, mm Hg 130 (120, 140) 130 (120, 140) 130 (120, 140) 0.039
DBP, mm Hg 80 (70, 85) 80 (70, 82) 80 (70, 85) 0.024
Type of AF 0.247
 Persistent 11,485 (81.1) 116 (75.8) 11,369 (81.1)
 Paroxysmal 2,490 (17.6) 34 (22.2) 2,456 (17.5)
 Newly diagnosed 196 (1.4) 3 (2.0) 193 (1.4)
Previous medication use
 Aspirin 5,184 (36.6) 65 (42.5) 5,119 (36.5) 0.128
 VKA 8,853 (62.3) 113 (73.9) 8,740 (62.3) 0.004
CHADS2 score 3.5 _ 0.9 3.5 _ 1.0 3.5 _ 0.9 0.928
CHADS2 score
 1 3 (0.0) 0 (0.0) 3 (0.0)
 2 1,857 (13.1) 25 (16.3) 1,832 (13.1)
 3 6,169 (43.5) 60 (39.2) 6,109 (43.6)
 4 4,067 (28.7) 40 (26.1) 4,027 (28.7)
 5 1,797 (12.7) 26 (17.0) 1,771 (12.6)
 6 278 (2.0) 2 (1.3) 276 (2.0)
Coexisting condition
 Prior stroke/TIA/non-CNS
embolism
7,767 (54.8) 86 (56.2) 7,681 (54.8) 0.726
 Congestive HF 8,851 (62.5) 82 (53.6) 8,769 (62.6) 0.023
 Hypertension 12,824 (90.1) 132 (86.3) 12,692 (90.5) 0.074
 Diabetes 5,647 (39.9) 75 (49.0) 5,572 (39.7) 0.020
 Prior MI 2,446 (17.3) 50 (32.7) 2,396 (17.1) <.001
 PAD 832 (5.9) 18 (11.8) 814 (5.8) 0.002
 COPD 1,481 (10.5) 17 (11.1) 1,464 (10.4) 0.790
 CrCl, ml/min* 67 (52, 87) 71 (53, 88) 67 (52, 87) 0.483

Values are median (25th, 75th percentile), n (%), or mean _ SD.

*

Creatinine clearance was calculated using the Cockcroft-Gault equation.

AF ¼ atrial fibrillation; BMI ¼ body mass index; CHADS2 ¼ Congestive Heart Failure, Hypertension, Age $75 Years, Diabetes Mellitus [1 point for presence of each], and Stroke/TIA [2 points]; scores range from 0 to 6; CNS ¼ central nervous system; COPD ¼ chronic obstructive pulmonary disease; CrCl ¼ creatinine clearance; DBP ¼ diastolic blood pressure; HF ¼ heart failure; MI ¼ myocardial infarction; PAD ¼ peripheral artery disease; PCI ¼ percutaneous coronary intervention; SBP ¼ systolic blood pressure; SD ¼ standard deviation; TIA ¼ transient ischemic attack; VKA ¼ vitamin K antagonist.